Sources | Names Used |
---|---|
CTRPv2 | selumetinib:piperlongumine (8:1 mol/mol) |
PharmacoGx | selumetinib:piperlongumine (8:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | RP11-229P13.27 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.009 |
mRNA | C6orf226 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.009 |
mRNA | SERPINE2 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.009 |
mRNA | RDH8 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.009 |
mRNA | POLR2D | CTRPv2 | pan-cancer | AAC | -0.1 | 0.009 |
mRNA | VPS4A | CTRPv2 | pan-cancer | AAC | -0.091 | 0.009 |
mRNA | SELM | CTRPv2 | pan-cancer | AAC | -0.098 | 0.009 |
mRNA | AC240274.1 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.009 |
mRNA | MPZ | CTRPv2 | pan-cancer | AAC | 0.099 | 0.009 |
mRNA | TBC1D9 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.009 |